Marshall Wace’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$698K Buy
+6,578
New +$698K ﹤0.01% 1882
2025
Q1
Sell
-59,381
Closed -$7.31M 2692
2024
Q4
$7.31M Buy
+59,381
New +$7.31M 0.01% 838
2024
Q3
Sell
-82,959
Closed -$8.85M 2535
2024
Q2
$8.85M Sell
82,959
-185,165
-69% -$19.8M 0.01% 712
2024
Q1
$32.3M Buy
268,124
+238,889
+817% +$28.8M 0.05% 311
2023
Q4
$3.6M Buy
+29,235
New +$3.6M 0.01% 851
2023
Q3
Sell
-11,153
Closed -$1.38M 2096
2023
Q2
$1.38M Buy
+11,153
New +$1.38M ﹤0.01% 1277
2023
Q1
Sell
-12,198
Closed -$1.94M 2367
2022
Q4
$1.94M Buy
+12,198
New +$1.94M ﹤0.01% 1370
2021
Q2
Sell
-17,910
Closed -$2.94M 2304
2021
Q1
$2.94M Buy
17,910
+10,391
+138% +$1.71M 0.01% 994
2020
Q4
$1.24M Buy
+7,519
New +$1.24M 0.01% 1015
2020
Q3
Sell
-39,806
Closed -$4.39M 1718
2020
Q2
$4.39M Buy
39,806
+39,654
+26,088% +$4.38M 0.03% 496
2020
Q1
$15K Sell
152
-252,352
-100% -$24.9M ﹤0.01% 1520
2019
Q4
$37.7M Buy
252,504
+251,551
+26,396% +$37.6M 0.26% 81
2019
Q3
$122K Buy
+953
New +$122K ﹤0.01% 1324
2019
Q2
Sell
-14,363
Closed -$2.05M 1545
2019
Q1
$2.05M Buy
14,363
+1,928
+16% +$276K 0.02% 720
2018
Q4
$1.54M Buy
+12,435
New +$1.54M 0.02% 787
2017
Q4
Sell
-37,944
Closed -$5.54M 440
2017
Q3
$5.54M Hold
37,944
0.26% 86
2017
Q2
$5.92M Buy
37,944
+2,143
+6% +$334K 0.26% 78
2017
Q1
$5.19M Sell
35,801
-32,686
-48% -$4.74M 0.25% 87
2016
Q4
$7.47M Sell
68,487
-233,848
-77% -$25.5M 0.05% 387
2016
Q3
$36.7M Buy
302,335
+186,998
+162% +$22.7M 0.26% 94
2016
Q2
$16.3M Buy
+115,337
New +$16.3M 0.14% 161
2016
Q1
Sell
-36,242
Closed -$5.09M 1106
2015
Q4
$5.09M Buy
36,242
+3,529
+11% +$496K 0.05% 373
2015
Q3
$4.35M Buy
32,713
+17,956
+122% +$2.38M 0.05% 319
2015
Q2
$2.6M Buy
+14,757
New +$2.6M 0.03% 413
2015
Q1
Sell
-13,032
Closed -$2.13M 865
2014
Q4
$2.13M Buy
13,032
+11,595
+807% +$1.9M 0.03% 446
2014
Q3
$231K Hold
1,437
﹤0.01% 751
2014
Q2
$211K Sell
1,437
-863
-38% -$127K ﹤0.01% 841
2014
Q1
$319K Buy
+2,300
New +$319K 0.01% 695
2013
Q2
$206K Buy
+3,000
New +$206K 0.01% 114